Dynavax Technologies | 판매 매출 총 이익

Gross Profit On Sales 변화 날짜
AbbVie USD 9.56B 95M 2023-09
Adma Biologics USD 31.09M 6.43M 2023-12
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Dynavax Technologies USD 46.91M 9.38M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Merck USD 11.29B 441M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
TG Therapeutics USD 36.12M 126.19M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Dynavax Technologies 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.